Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Barriers to Successful Research Compensation in a Multicenter Pediatric Acute Care Study.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2026

Same author

Screening Emotions in Adolescents Receiving Care at the Hospital for mild Traumatic Brain Injury (SEARCH-mTBI): protocol for a multicenter observational study.

BMC pediatrics·2026

Same author

Mitigation of Racial and Ethnic Differences in Chlamydia and Gonorrhea Testing.

Pediatrics open science·2026

Same author

Calcitonin Gene-Related Peptide for Identifying Pediatric Bacterial Musculoskeletal Infections: A Prospective, Multicenter Study.

Pediatric emergency care·2025

Same author

Hospital Variations in Time-To-Crisis-Resolution Among Children and Adolescents With Sickle Cell Disease.

American journal of hematology·2025

Same author

Gonorrhea and Chlamydia Screening for Adolescents and Young Adults in Emergency Departments.

JAMA pediatrics·2025

Search research articles

Related Experiment Video

Updated: Sep 2, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Childhood tuberculosis.

Lindsay H Cameron¹, Andrea T Cruz^1,2

¹Department of Pediatrics, Sections of Infectious Diseases.

Current Opinion in Infectious Diseases

|August 10, 2022

Summary

This summary is machine-generated.

Identifying children at risk for tuberculosis requires updated strategies. Recent advancements in interferon gamma release assays (IGRAs) and molecular testing aid diagnosis, while shorter treatment regimens are available but have limitations.

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Related Experiment Videos

Last Updated: Sep 2, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Area of Science:

Pediatrics
Infectious Diseases
Public Health

Background:

The management of pediatric tuberculosis (TB) is increasingly complex due to the SARS-CoV-2 pandemic, broader use of immunosuppressants, and evolving treatment protocols.
New diagnostic tools and shorter treatment regimens have emerged, but their application requires careful consideration of patient factors and potential drug interactions.

Purpose of the Study:

To review the latest literature on identifying children at risk for tuberculosis.
To outline optimal testing and treatment strategies for pediatric tuberculosis.
To address the challenges posed by the SARS-CoV-2 pandemic and other factors on TB management in children.

Main Methods:

Literature review of recent studies on pediatric tuberculosis diagnosis and treatment.
Analysis of the impact of SARS-CoV-2 pandemic on global TB control efforts.
Evaluation of interferon gamma release assays (IGRAs) and molecular-based tests for TB diagnosis in children.

Main Results:

The SARS-CoV-2 pandemic is expected to negatively affect global tuberculosis control.
Interferon gamma release assays (IGRAs) and molecular-based testing show promise for improving pediatric TB diagnosis.
Shorter, rifamycin-containing treatment regimens are available for pediatric TB infection, but drug-drug interactions limit their use in some immunosuppressed children.

Conclusions:

A comprehensive approach to identifying and managing children at risk for tuberculosis is crucial.
Enhanced utilization of IGRAs and molecular-based testing is supported by growing evidence for improved pediatric TB diagnosis.
Providers must remain aware of the challenges impacting pediatric TB identification and treatment, including pandemic-related disruptions and limitations of shorter treatment regimens in specific populations.